Lacidipine
- Generic Name
- Lacidipine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C26H33NO6
- CAS Number
- 103890-78-4
- Unique Ingredient Identifier
- 260080034N
- Background
Lacidipine is a lipophilic dihydropyridine calcium antagonist with an intrinsically slow onset of activity. Due to its long duration of action, lacidipine does not lead to reflex tachycardia . It displays specificity in the vascular smooth muscle, where it acts as an antihypertensive agent to dilate peripheral arterioles and reduce blood pressure. Compared t...
- Indication
Indicated for the treatment of hypertension either alone or in combination with other antihypertensive agents, including β-adrenoceptor antagonists, diuretics, and ACE-inhibitors .
- Associated Conditions
- Hypertension
- Associated Therapies
- -
Effect of Caldine® on Renal Function in Balanced Hypertension
- First Posted Date
- 2014-09-16
- Last Posted Date
- 2014-09-16
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 5417
- Registration Number
- NCT02240641
A Randomised, Parallel-group, Double-blind, Double-dummy Study to Compare the Effects of Lacidipine Versus Bendrofluazide on Markers of Platelet Activation and Haemorheological Factors in Hypertensive Patients
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-09-10
- Last Posted Date
- 2014-09-10
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 26
- Registration Number
- NCT02235402
Tolerability and Pharmacokinetics of Telmisartan in Combination With Lacidipine in Healthy Male Subjects
- First Posted Date
- 2014-08-18
- Last Posted Date
- 2014-08-18
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 27
- Registration Number
- NCT02218684
Bioavailability of Lacidipine and Telmisartan Fixed Dose Combination Tablets Relative to Separate Tablets in Healthy Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-08-06
- Last Posted Date
- 2014-08-06
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 12
- Registration Number
- NCT02209649
Tolerability and Pharmacokinetics of Lacidipine With and Without the Co-administration of Telmisartan in Female and Male Healthy Subjects
- First Posted Date
- 2014-07-30
- Last Posted Date
- 2014-08-06
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 26
- Registration Number
- NCT02203500
Lacidipine in Medical Practice in Patients With Mild to Moderate Essential Hypertension
- First Posted Date
- 2014-06-27
- Last Posted Date
- 2014-07-14
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 53
- Registration Number
- NCT02177331
Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-05-24
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- GlaxoSmithKline
- Registration Number
- NCT00328965
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath